
In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 …

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …

AbbVie revealed that its IL-23 inhibitor, risankizumab, had successfully met all of its endpoints in a Phase 3 trials into …

We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement …
Mundipharma has announced that it has appointed Philippe Mazas as its new Chief Information Officer (CIO). Mazas boasts nearly 20 …

Akili, an unlisted affiliate of London-listed PureTech Health, has unveiled top-line results of AKL-T01, a novel digital medicine which takes …

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of …

The conflict and poor economic situation in Yemen is creating a “perfect mix” for a resurgence of cholera in the …

The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns …

The FDA has announced the approval of Mylan’s Ogivri (trastuzumab-dkst), the first biosimilar version of Roche’s Herceptin to be authorised …

As part of Johnson & Johnson’s acquisition of Actelion, it was able to secure a number of ties with the …

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

We’re officially into December and only one month away from the end of the year. Among our top news this …

Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century …